Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Erbium:Yag Laser vs Hyaluronic Acid Suppository for GSM in Breast Cancer (BC)

NCT03816735 is registered in ClinicalTrials.gov with Medical University of Graz as lead sponsor.

NCT NCT03816735
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03816735 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Erbium:Yag Laser vs Hyaluronic Acid Suppository for GSM in Breast Cancer (BC)
Lead sponsor
Medical University of Graz
Phase
Not applicable
Overall status
Unknown status
Start date
January 24, 2019
Completion date
December 31, 2024
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

urogenital disease